Clinical Trial

Infant Malaria Vaccine Schedule Optimization

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The aim of this study is to identify an optimal infant vaccine schedule for a malaria vaccine which is better aligned with the timing of other vaccine interventions.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-03-11; most recent amendment 2026-05-13.
Status change: Not Yet Recruiting → Recruiting 2025-06-04
Trial Details
NCT Number NCT06879327
Lead Sponsor PATH
Collaborators: Pharmassist Ltd, Serum Institute of India Pvt. Ltd., Agilis, MCT-CRO, Cytespace
Conditions Malaria Vaccines
Enrollment 964 participants
Start Date 2025-05-30
Primary Completion 2027-09-27 (estimated)
Study Completion 2027-09-27 (estimated)
Updated on ClinicalTrials.gov 2026-05-15